Nexaph peptides represent a groundbreaking clinical strategy targeting disease progression. These engineered entities leverage the specific properties of short peptide sequences to modulate cellular processes involved in reaction, tissue repair, and neoplasm growth. Investigations suggest their potential for treating a Nexaph peptides spectrum of c